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Abstract
A number of studies point at platelet monoamine oxi-
dase (MAO) activity being reduced in alcoholics with a
family history of drinking, this being a possible vulnera-
bility marker for alcoholism. To test this hypothesis, we
examined a group of recently detoxified alcoholics with
high (n = 25) and low genetic loading for alcoholism (n =
28) and a group of healthy controls (n = 21). Clinical
assessments were made using the SCID II interview for
psychiatric disorders, the Family History Assessment
Module and the Semi-Structural Assessment of Genetics
in Alcoholism, a questionnaire especially designed for
genetic studies. Platelet MAO activity with and without
ethanol stimulation and the percentage of MAO activity
with ethanol did not differ between groups. The only sig-
nificant difference was a lower inhibition of MAO activity
with ethanol in alcoholics both with and without a family
history compared to controls. In patients with antisocial
personality traits, platelet MAO activity was also not
found to be different from other alcoholics. Our findings
question the hypothesis of reduced platelet MAO activity
to be a possible vulnerability marker for alcoholism.
Copyright © 2000 S. Karger AG, Basel
Monoamine oxidase (MAO) is a mitochondrial en-
zyme involved in the metabolism and breakdown of sev-
eral major neurotransmitter amines such as dopamine
and serotonin. There are two distinct forms: type A which
is involved in the metabolism of serotonin and norepi-
nephrine and type B which degrades phenylethylamine
and benzylamine. Only the latter form can be found in
platelets [1]. The genes for MAO-A and MAO-B are
located in the short arm of human X chromosome 8 (Xp
11.3). Over 50 variations of MAO-A and MAO-B activi-
ties have been shown in humans.
Decreased platelet MAO (MAO-B; EC 1.4.3.4) activity
in alcoholics compared to controls has been demonstrated
in numerous studies [2–7], although some studies failed to
show this effect [8, 9]. Since alcoholism is a very heteroge-
nous disorder with multiple subgroups, more recent stud-
ies have tried to link reduced MAO-B activity in alcohol-
ics with certain personality traits or family history of alco-
Gender, male/female
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Table 1. Characteristics of inpatients with regard to family history
FHP alcoholics FHN alcoholics Controls F/T value Significance
22/3 21/7 9/13
Age, years 37.1B7.4 43.7B11.0 33.7B11.1 7.77 0.008
Alcoholics
Alcoholism age of onset 26.3B7.0 31.7B9.0 –2.09 0.041
Daily alcohol intake, g/dl 239.6B99.7 206.9B97.81 n.s.
F/T value from ANOVA or t test.
holism. In some studies, a reduced MAO-B activity in
alcoholics was associated with type 2 alcoholism [10], a
subtype which associated with high heritability, early age
of onset and severe social and legal consequences of alco-
holism [5, 11–15]. Unfortunately, a possible correlation
of reduced MAO-B activity and certain subtypes of alco-
holism could not be demonstrated in all studies. Yates et
al. [16] were not able to demonstrate a reduced platelet
MAO activity in type 2 alcoholics, and a more recent
study by Parsian et al. [17] also failed to show differences
in MAO-B activity between alcoholics and nonalcoholic
controls, and between type 1 and type 2 alcoholics. The
allele frequency distribution for the MAO-A and MAO-B
dinucleotide repeats was different between the alcoholic
and the control sample. A reduced MAO-B activity may
also be associated with violence, aggressive behavior and
antisocial personality traits [18, 19].
Especially the possible association of reduced platelet
MAO-B activity and family history of alcoholism has
attracted substantial attention in recent years. A reduced
activity has also been shown in relatives of alcoholics [2,
4, 20, 21]. The activity of MAO is genetically determined
[22], and twin studies suggest a minimum heritability of
0.75 for platelet MAO activity [23]. Some studies show
that individual platelet MAO activity is also quite stable
over time [6, 24], but this has been questioned by others
[25, 26]. MAO activity has been advocated as a possible
vulnerability marker for alcoholism [27–29], although
more recent studies in alcoholic families failed to show
any clear pattern [30]. Still more studies are necessary to
explore the possible link of MAO activity with family his-
tory of alcoholism.
The other major question adressed in this study is
whether certain personality traits such as sensation seek-
ing, impulsiveness and monotony avoidance may be
linked with low platelet activity. Rommelspacher et al.
[31] found a significantly lower platelet MAO-B activity
in alcoholics with high novelty-seeking and impulsiveness
scores as measured by the Tridimensional Personality
Questionnaire [10, German version 32] but these findings
also need further confirmation.
To further examine the possible role of reduced MAO
activity as a vulnerability marker for alcoholism and its
possible association with high genetic loading for alcohol-
ism, we conducted a study in recently detoxified alcohol-
ics with a high and low genetic loading for alcoholism.
Subjects and Methods
Methods
We examined 53 psychiatric inpatients who met the ICD-10 and
DSM-III-R criteria for alcohol dependence and 21 sex- and age-
matched healthy controls (hospital staff and town community well-
known to the investigators). Patient characteristics are given in
tables 1 and 2. As expected, patients with a positive family history of
alcoholism were found to have a significantly lower age of onset for
alcoholism. They also were younger on examination. Patients with
antisocial personality (ASP) traits were exclusively male and had a
higher daily alcohol consumption compared to other alcoholics (ta-
ble 2). Patients had been detoxified and were abstinent for at least 14
days before testing. Patients did not have a history for any other
major psychiatric disorder including affective disorder, schizophre-
nia or polysubstance abuse. The latter was ruled out both clinically
and by toxicological urine analysis.
Laboratory Investigation
Thirty milliliters of blood were drawn by venipuncture using Na-
EDTA as anticoagulant (10 mg/10 ml blood). After centrifugation at
130 g for 20 min at room temperature, the resulting platelet-rich plas-
ma was spun down at 2,000 g for 15 min at 4 °C, washed once in
phosphate buffer (NaCl 140 mmol/l; Na2PO4 8.6 mmol/l; glucose 11
mmol/l; pH 7.2). The final pellet was immediately frozen at minus
70°C, enzyme determination was carried out not later than 4 weeks
after blood sampling.
For investigation of MAO-B activity the platelet pellet was
thawed, homogenized using an Ultrathurrax, suspended in phos-
phate-buffered saline (pH 7.4) to give a final protein concentration of
2 mg/ml. Of this protein suspension, 100 Ìl were incubated with the
Gender, male/female
Platelet MAO and Family History of
Drinking
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Table 2. Characteristics of inpatients with regard to antisocial personality
ASPD Non-ASPD T/F value Significance
19/0 29/6
Age, years 40.5B10.8 39.8B7.1 n.s.
Alcoholics
Alcoholism age of onset 29.1B8.1 31.0B11.0 n.s.
Daily alcohol intake, g/d 278.9B160.3 198.7B78.76 –1.98 0.053
ASPD = Alcoholics with antisocial personality disorder; Non-ASPD = alcoholics without antisocial personality
disorder.
substrate 14C-tryptamine (2.4 Ìmol/l; Dupont-NEN) in absence or
presence of 400 mmol/l ethanol in a total volume of 350 Ìl for 30 min
at 37°C. The reaction was stopped with 400 Ìl HCl (2 N), all further
procedures were carried out on ice. After addition of 6 ml toluol, the
samples were thoroughly mixed, incubated for 10 min and centri-
fuged at 600 g for 10 min at 4 °C. Four milliliters of the supernatant
were mixed with 10 ml scintillation fluid (Ultima Gold, Canberra
Packard) and counted in a ß-scintillation counter (Beckmann); effi-
ciency 50%. MAO-B activity was calculated as nanomoles of product
formed per milligram protein per hour. All samples were measured in
triplicate with an average deviation below 10%.
Study Sample and Questionnaires
Alcoholic inpatients were divided into patients with (family his-
tory positive, FHP, n = 25) and without (family history negative,
FHN, n = 28) family history. Patients were defined as FHP probands
if they had at least 1 first-degree relative and 1 additional relative
with alcohol dependence reported. In the FHN group, patients did
not have any relative with alcohol abuse or dependence.
Psychological assessments were made using the SCID II inter-
view. ASP traits were determined using the SCID II questionnaire
according to DSM-III-R diagnosis criteria. Alcoholics were subdivid-
ed into subjects with ASP disorder if they positively answered 3 or
more out of 10 questions of the SCID II adult ASP disorder scale.
All the patients recruited in our study signed an informed consent
according to the declaration of Hongkong (1989) and the guidelines
of good clinical practice.
Family history of alcoholism was obtained using the Family His-
tory Assessment Module [33], a questionnaire for both alcoholic
patients and their relatives. To confirm the patients reports, one of
the patients’ relatives without any known alcohol problem was asked
about the patient and his family, if possible. Unfortunately, 60% of
the study population reported to have no contact with any relatives
or refused to let the investigators seek contact with any of their rela-
tives.
All questionnaires were given to the patients after alcohol with-
drawal. Criteria for alcohol dependence or other substance abuse
were obtained using the SCID-II questionnaire according to DSM-
III-R. Additional data concerning alcoholism were obtained using a
translated German version of the Semi-Structured Assessment of
Genetics in Alcoholism questionnaire [34], an instrument frequently
used in genetic studies in alcoholics. Age of onset of alcoholism was
computed using 3 items: first age of frequent drinking, first age of loss
of control over alcohol intake and first age when social problems or
problems with relatives, spouse or friends due to alcohol consump-
tion appeared.
Data Analysis
Statistics were performed using SPSS Software (Ver. 6.1.3., SPSS
Inc, Chicago, 1994). All MAO data were tested for normal distribu-
tion.
Differences of MAO activity between the alcoholic subgroups
and controls were tested by a one-way ANOVA. A significance level
of 0.05 was chosen for all statistical analyses.
Results
Platelet MAO activity was investigated in 53 alcoholic
patients, defined as FHP (n = 25) or FHN (n = 28) and 21
healthy controls. Basal MAO-B activities were on a simi-
lar level in all groups (fig. 1). After addition of ethanol, the
mean data were decreased in all groups, without being
able to distinguish between FHP, FHN and controls
(fig. 2). However, a significant difference could be found
as far as the percentage of enzyme inhibition with and
without ethanol is concerned. Thus FHP and FHN pa-
tients showed a lower percentage of ethanol inhibition of
MAO-B activity than was observed in healthy controls
(F = 6.01, d.f. 2.73, p = 0.003, fig. 3, 4).
MAO-B activity in male alcoholics (n = 44) did not dif-
fer from that in female ones (n = 9), neither in basal
enzyme activity (4.03 vs. 4.76 nmol/mg/h) nor after etha-
nol inhibition (3.31 vs. 3.99 nmol/mg/h).
Nineteen patients were found to meet the DSM-III-R
criteria for ASP obtained by SCID-II interview. Platelet
MAO activity in these individuals did not differ from
those patients who did not meet the criteria (n = 35) or
healthy controls (fig. 5, 6). The only statistical difference
observed was a lower percentage of inhibition of MAO
activity in both ASP-positive and -negative alcoholics
compared to controls (F = 6.34, d.f. = 2,72, p = 0.003).
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Fig. 1. MAO activity without ethanol in alcoholics with and without
a family history of drinking and controls. i = FHP; n = FHN;
g = controls.
Fig. 2. MAO activity with ethanol in alcoholics with and without a
family history of drinking and controls. i = FHP; n = FHN;
g = controls.
Fig. 3. Inhibition of MAO activity by ethanol in alcoholics with and
without a family history of drinking and controls. i = FHP;
n = FHN; g = controls. * p ! 0.05.
Fig. 4. MAO activity without ethanol in alcoholics meeting and not
meeting criteria for ASP and controls. i = ASP; n = non-ASP;
g = controls.
Platelet MAO and Family History of
Drinking
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Fig. 5. MAO activity with ethanol in alcoholics meeting and not
meeting criteria for ASP and controls. i = ASP; n = non-ASP;
g = controls.
Fig. 6. Inhibition of MAO activity by ethanol in alcoholics meeting
and not meeting criteria for ASP and controls. i = ASP; n = non-
ASP; g = controls. * p ! 0.05.
Discussion
In the present study, we were unable to demonstrate
any significant differences in MAO activity both with and
without ethanol inhibition between FHP and FHN alco-
holics and healthy controls. We were also unable to find
any significant differences concerning MAO activity in
patients with and without ASP traits. The only significant
difference was a lower percentage of inhibition of MAO
activity with ethanol in patients compared to controls.
The latter finding is consistent with previous studies as
cited above.
A number of methodological problems may account
for this result. Firstly, the number of patients studied in
our sample was comparatively small, which was especially
the case for patients with ASP traits.
Second, a number of possible variables may influence
platelet MAO activity, as recently reviewed by Farren
[35]. While Farren [35] concluded that MAO activity is
stable in the post-withdrawal period from about 4 weeks
of abstinence onward, and that it is unlikely that different
assay methods contribute to the different findings in some
studies, gender issues have been poorly examined. The
COGA study recently reported that female alcoholics had
a lower platelet MAO activity than female controls [36].
Other studies have shown mixed results [5, 16, 37, 38]. In
our sample, we could not demonstrate any differences
between male and female alcoholics, but the number of
females was comparatively low. Another possible con-
founding variable is polysubstance abuse being of possible
importance for the MAO activity, but this had been ruled
out in our patients.
Thirdly, the concentration of ethanol used in our
experiment (400 mM) was relatively high. Although this is
a dosage also used by other researchers, it might be of
interest to study lower dosages of alcohol also. Still, taken
the wide range of MAO activity into account, there is little
reason to expect more robust findings.
While the possible role of platelet MAO activity as a
vulnerability marker for alcoholism in general can be
questioned on the basis of our own data and most of the
studies published so far [35], its possible role as a marker
for different types of alcoholics is still a matter of debate.
Cloninger [39] proposed two types of alcoholics: type 1
being characterized by late age of onset, environmental
precipitation, weak family history for alcoholism, absence
of antisocial traits and fairly equal distribution between
sexes, and the male-limited type 2 with early onset of alco-
holism, lack of environmental precipitants and strong
antisocial traits. Farren [35] concluded that if MAO activ-
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ity was indeed a marker for alcoholism, it might be
expected to be more significantly diminished in the type 2
or the more strongly genetic form of alcoholism. Both
hypotheses were examined in our sample, but we did not
find any evidence for either. Some authors [11, 12] found
a significantly diminished activity in type 2 alcoholics
compared to type 1 alcoholics and controls. Pandey et al.
[5] found lower MAO activity to be associated with young
age, lower age of onset of alcoholism and higher frequency
of family history of alcoholism. Similarly, Sherif et al. [40]
reported a difference between type 2 alcoholics and con-
trols, but not between alcoholics overall and controls.
Unfortunately, other groups failed to find any differences
between certain subtypes of alcoholics [16, 38, 41]. More
recent provisional data of the large COGA study also did
not show any differences in MAO activity between differ-
ent subtypes of alcoholics [36]. Still, early-onset male alco-
holics tended to have a lower platelet MAO activity.
Other psychopathological symptoms or personality
traits may also be of relevance for platelet MAO activity,
among others. However, similar to our findings, Farren et
al. [38] and Anthenelli et al. [41] could not demonstrate
differences in platelet MAO activity when divided by pri-
macy of ASP disorder. Whether a history of affective dis-
order might be a risk factor for low platelet MAO activity
in alcoholics is a matter of debate [5, 12], but the patients
studied in our sample did not have any history of major
psychiatric disorders such as depression. A number of
personality traits might also contribute to different results
in different clinical samples [for review see 35]. The most
important issue might be a possible association with
aggressive behavior and ‘sensation seeking’, and a possi-
ble negative correlation with impulsivity [14, 35, 42, 43].
In conclusion, our data suggest that platelet MAO
activity in alcoholics with high genetic loading for alcohol-
ism does not differ from alcoholics without family history
for alcoholism or controls. Also, MAO activity in alco-
holic patients with ASP traits did not differ from those in
other alcoholics. Although platelet MAO activity seems to
be controlled to a large extent by genetic factors, taking
into account the wide range of data and the large number
of clinical, biological and psychological variables being
possibly associated with differences in MAO activity and
the nonspecificity of reduced MAO activity at present, a
reduced platelet MAO activity cannot be considered as a
reliable vulnerability marker for alcoholism. Future re-
search in this field should focus on special subtypes of
alcoholics being characterized by certain biological, genet-
ic or psychological characteristics.
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